Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SMBS
Schwab Mortgage-Backed Securities ETF
SMBS
|
+$5.08B |
| 2 |
Schwab Municipal Bond ETF
SCMB
|
+$1.29B |
| 3 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$752M |
| 4 |
Microsoft
MSFT
|
+$699M |
| 5 |
NVIDIA
NVDA
|
+$578M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$4.9B |
| 2 |
Invesco FTSE RAFI US 1000 ETF
PRF
|
+$986M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$951M |
| 4 |
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
|
+$794M |
| 5 |
Schwab Fundamental International Small Company Index ETF
FNDC
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.55% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 9.33% |
| 4 | Consumer Discretionary | 9.25% |
| 5 | Industrials | 8.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Sunrun
RUN
$2.37B
| $18.2M | ﹤0.01% |
2,230,326
+236,032
| +12% | +$1.86M |
|
1727
Boston Beer
SAM
$1.89B
| $18.2M | ﹤0.01% |
95,389
-4,068
| -4% | -$936K |
|
1728
Pediatrix Medical
MD
$2.15B
| $18.2M | ﹤0.01% |
1,267,943
+142,991
| +13% | +$1.96M |
|
1729
SiriusPoint
SPNT
$2.66B
| $18.2M | ﹤0.01% |
891,703
+36,648
| +4% | +$674K |
|
1730
Rogers Corp
ROG
$2.48B
| $18.1M | ﹤0.01% |
264,702
+10,396
| +4% | +$670K |
|
1731
Omnicell
OMCL
$1.69B
| $18.1M | ﹤0.01% |
616,023
+2,265
| +0.4% | +$67.7K |
|
1732
Safety Insurance
SAFT
$1.52B
| $18.1M | ﹤0.01% |
227,482
-4,128
| -2% | -$326K |
|
1733
Warby Parker
WRBY
$3.13B
| $18M | ﹤0.01% |
822,873
+78,284
| +11% | +$1.45M |
|
1734
Trupanion
TRUP
$1.33B
| $17.9M | ﹤0.01% |
323,997
+22,444
| +7% | +$994K |
|
1735
Ecovyst
ECVT
$1.09B
| $17.8M | ﹤0.01% |
2,164,987
+58,038
| +3% | +$407K |
|
1736
Schneider National
SNDR
$6.27B
| $17.8M | ﹤0.01% |
736,249
-34,570
| -4% | -$803K |
|
1737
Worthington Steel
WS
$1.94B
| $17.8M | ﹤0.01% |
595,717
+139,775
| +31% | +$3.6M |
|
1738
Stock Yards Bancorp
SYBT
$2.64B
| $17.7M | ﹤0.01% |
223,804
+5,546
| +3% | +$405K |
|
1739
Coty
COTY
$2.43B
| $17.7M | ﹤0.01% |
3,799,625
+264,195
| +7% | +$1.31M |
|
1740
BioCryst Pharmaceuticals
BCRX
$2.71B
| $17.7M | ﹤0.01% |
1,969,875
+47,837
| +2% | +$445K |
|
|
CSR
1741
Centerspace
CSR
$925M
| $17.6M | ﹤0.01% |
292,761
+33,129
| +13% | +$2.03M |
|
1742
IDT Corp
IDT
$1.63B
| $17.6M | ﹤0.01% |
257,908
+79,643
| +45% | +$4.56M |
|
1743
UFP Technologies
UFPT
$2.5B
| $17.6M | ﹤0.01% |
72,065
+4,527
| +7% | +$1.02M |
|
|
NVEE
1744
DELISTED
NV5 Global
NVEE
| $17.6M | ﹤0.01% |
760,634
-6,553
| -0.9% | -$131K |
|
1745
Azenta
AZTA
$1.47B
| $17.6M | ﹤0.01% |
570,548
+136,207
| +31% | +$3.83M |
|
1746
Leggett & Platt
LEG
$1.29B
| $17.5M | ﹤0.01% |
1,967,069
+507,151
| +35% | +$4.37M |
|
1747
Sony
SONY
$138B
| $17.5M | ﹤0.01% |
671,003
+108,200
| +19% | +$2.71M |
|
1748
Vertex
VERX
$2B
| $17.5M | ﹤0.01% |
494,230
+61,420
| +14% | +$2.34M |
|
1749
FB Financial Corp
FBK
$3.1B
| $17.4M | ﹤0.01% |
384,385
+16,924
| +5% | +$736K |
|
1750
CTS Corp
CTS
$1.82B
| $17.4M | ﹤0.01% |
408,370
+15,047
| +4% | +$608K |
|
Similar funds
Charles Schwab's Q2 2025 Portfolio in Review
As of Q2 2025, Charles Schwab held 3,631 positions worth $578B, up 8.5% from $533B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Charles Schwab's Q2 2025 filing shows 158 new, 2,252 increased, 1,020 reduced and 137 closed positions. Its largest new stake was Schwab Mortgage-Backed Securities ETF: 202,020,489 shares worth $5.15B. The largest sale was Vanguard Mortgage-Backed Securities ETF, an estimated $4.9B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2025 buy was Schwab Mortgage-Backed Securities ETF: 202,020,489 shares worth $5.15B.
- Charles Schwab added most to Schwab Municipal Bond ETF in Q2 2025, an estimated $1.29B increase.
- Charles Schwab's biggest Q2 2025 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $4.9B.
- Charles Schwab fully exited Invesco FTSE RAFI US 1000 ETF in Q2 2025, selling an estimated $986M.
- Charles Schwab's ten largest holdings make up 23% of its $578B portfolio in Q2 2025.
- Charles Schwab opened 158 new positions and closed 137 in Q2 2025.
- Charles Schwab's portfolio value rose 8.5% quarter-over-quarter to $578B.
Based on Charles Schwab's 13F filing for Q2 2025, filed 12 Aug 2025.